Immuno-PET Imaging of HER3 in a Model in which HER3 Signaling Plays a Critical Role

作者: Qinghua Yuan , Takako Furukawa , Takahiro Tashiro , Kouki Okita , Zhao-Hui Jin

DOI: 10.1371/JOURNAL.PONE.0143076

关键词:

摘要: HER3 is overexpressed in various carcinomas including colorectal cancer (CRC), which associated with poor prognosis, and involved the development of therapy resistance. Thus, an vivo imaging technique needed to evaluate expression HER3, important therapeutic diagnostic target. Here, we report successful PET using a newly generated anti-human monoclonal antibody, Mab#58, mouse model HER3-overexpressing xenograft tumor. Furthermore, assessed role signaling CRC tissue-originated spheroid (CTOS) applied detect endogenous CTOS-derived xenografts. Cell binding assays 89Zr-labeled Mab#58 cell line HER3/RH7777 demonstrated that [89Zr]Mab#58 specifically bound cells (Kd = 2.7 nM). In biodistribution study mice bearing its parent xenografts showed tumor accumulation was significantly higher than control from day 1 4, tending increase 4 reaching 12.2 ± 4.5%ID/g. Radioactivity other tissues, xenograft, decreased or remained unchanged 6. Positron emission tomography (PET) same enabled clear visualization but not RH7777 CTOS growth assay revealed were dependent on for their growth. studies clearly visualized antibody. successfully by anti-HER3 antibody xenograft-bearing mice, retains properties patient Non-invasive targeting antibodies feasible, it expected be useful diagnosis treatment.

参考文章(40)
Eric Wehrenberg-Klee, Pedram Heidari, Umar Mahmood, N. Selcan Turker, Bryan Chang, Development of a HER3 PET probe for breast cancer imaging The Journal of Nuclear Medicine. ,vol. 55, pp. 550- 550 ,(2014)
Hisato Kawakami, Isamu Okamoto, Kimio Yonesaka, Kunio Okamoto, Kiyoko Shibata, Yume Shinkai, Haruka Sakamoto, Michiko Kitano, Takao Tamura, Kazuto Nishio, Kazuhiko Nakagawa, The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells Oncotarget. ,vol. 5, pp. 11847- 11856 ,(2014) , 10.18632/ONCOTARGET.2663
Emily B. Corcoran, Robert N. Hanson, Imaging EGFR and HER2 by PET and SPECT: a review. Medicinal Research Reviews. ,vol. 34, pp. 596- 643 ,(2014) , 10.1002/MED.21299
Anton GT Terwisscha van Scheltinga, Marjolijn N Lub-de Hooge, Keelara Abiraj, Carolien P Schröder, Linda Pot, Birgit Bossenmaier, Marlene Thomas, Gabriele Hölzlwimmer, Thomas Friess, Jos GW Kosterink, Elisabeth GE de Vries, ImmunoPET and biodistribution with human epidermal growth factor receptor 3 targeting antibody Zr-89-RG7116 mAbs. ,vol. 6, pp. 1051- 1058 ,(2014) , 10.4161/MABS.29097
F. Lédel, M. Hallström, P. Ragnhammar, K. Öhrling, D. Edler, HER3 expression in patients with primary colorectal cancer and corresponding lymph node metastases related to clinical outcome European Journal of Cancer. ,vol. 50, pp. 656- 662 ,(2014) , 10.1016/J.EJCA.2013.11.008
Nancy E. Hynes, Heidi A. Lane, ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer. ,vol. 5, pp. 341- 354 ,(2005) , 10.1038/NRC1609
Hiroko Endo, Jiro Okami, Hiroaki Okuyama, Toru Kumagai, Junji Uchida, Jumpei Kondo, Tetsuo Takehara, Yasuko Nishizawa, Fumio Imamura, Masahiko Higashiyama, Masahiro Inoue, Spheroid culture of primary lung cancer cells with neuregulin 1/HER3 pathway activation. Journal of Thoracic Oncology. ,vol. 8, pp. 131- 139 ,(2013) , 10.1097/JTO.0B013E3182779CCF
Hiroshi Wakui, Noboru Yamamoto, Shinji Nakamichi, Yousuke Tamura, Hiroshi Nokihara, Yasuhide Yamada, Tomohide Tamura, Phase 1 and dose-finding study of patritumab (U3-1287), a human monoclonal antibody targeting HER3, in Japanese patients with advanced solid tumors Cancer Chemotherapy and Pharmacology. ,vol. 73, pp. 511- 516 ,(2014) , 10.1007/S00280-014-2375-2
J. A. Engelman, K. Zejnullahu, T. Mitsudomi, Y. Song, C. Hyland, J. O. Park, N. Lindeman, C.-M. Gale, X. Zhao, J. Christensen, T. Kosaka, A. J. Holmes, A. M. Rogers, F. Cappuzzo, T. Mok, C. Lee, B. E. Johnson, L. C. Cantley, P. A. Janne, MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Science. ,vol. 316, pp. 1039- 1043 ,(2007) , 10.1126/SCIENCE.1141478
P. M. Guy, J. V. Platko, L. C. Cantley, R. A. Cerione, K. L. Carraway, INSECT CELL-EXPRESSED P180ERBB3 POSSESSES AN IMPAIRED TYROSINE KINASE ACTIVITY Proceedings of the National Academy of Sciences of the United States of America. ,vol. 91, pp. 8132- 8136 ,(1994) , 10.1073/PNAS.91.17.8132